Baker Bros. increases stake in Genomic Health to 12% with recent stock purchase

By Lisa Kerner

Charlotte, N.C., March 13 - Genomic Health, Inc. investors Julian C. Baker and Felix J. Baker, along with their affiliates Baker Bros. Investments, LLP and related funds, bought 316,043 shares of the company's stock between March 1 and March 9 priced from $17.77 to $18.20.

The investors beneficially own 2,941,272 shares, or 12%, of the Redwood City, Calif., biotechnology company, according to a schedule 13D filing with the Securities and Exchange Commission.

Genomic Health (Nasdaq: GHDX) closed at $18.54 on March 12.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.